IPAP vs EPAP: Differences in Bilevel Therapy Settings

IPAP (inspiratory positive airway pressure) is the higher pressure delivered when you breathe in, while EPAP (expiratory positive airway pressure) is the lower pressure maintained when you breathe out. Together they form the two settings on a bilevel positive airway pressure device, commonly known as BiPAP. The difference between these two pressures drives how much air reaches your lungs on each breath, and each pressure serves a distinct physiological purpose that matters for comfort, effectiveness, and safety.

What Each Pressure Does

IPAP activates when you start to inhale. The machine ramps up to the set inspiratory pressure, pushing air into your lungs and assisting the muscles that expand your chest. This reduces the work your diaphragm has to do. In a study of patients with bronchospasm, applying inspiratory pressure cut the force the diaphragm needed to generate per unit of air from about 69 to 46 cmH₂O per liter, a meaningful reduction in breathing effort.¹ During sleep, inspiratory support also triggers a natural feedback loop: the brain detects that the lungs are getting help and dials down its own signals to the breathing muscles, essentially letting the machine share the workload.²

EPAP, on the other hand, is the baseline pressure that stays on when you exhale. It keeps positive pressure in your airway throughout the breathing cycle, which serves two purposes. First, it prevents the soft tissues of the throat from collapsing, acting like a pneumatic splint. Second, it helps keep the small air sacs in the lungs from deflating completely at end-expiration, which improves oxygen exchange. Research comparing CPAP (continuous pressure during both phases) with EPAP alone found that maintaining pressure during inspiration too, rather than only during expiration, produced better lung volumes and oxygenation in critically ill patients.³ This finding helps explain why bilevel therapy, which provides pressure during both phases but at different levels, became preferred over devices that only pressurize one phase.

Why the Gap Between Them Matters

The difference between IPAP and EPAP, sometimes called pressure support, is what determines how much extra air the machine pushes into your lungs with each breath. If IPAP is set to 14 cmH₂O and EPAP to 4 cmH₂O, that gap of 10 cmH₂O is the driving force behind each tidal breath. Raise EPAP while keeping IPAP the same, and you shrink the gap, which means less air per breath.

A study of 30 long-term ventilator users with conditions including scoliosis, obesity hypoventilation, and neuromuscular disease demonstrated this directly. While IPAP stayed constant, adding 5 cmH₂O of EPAP reduced the average breath volume by about 167 ml. Adding 10 cmH₂O of EPAP cut it by roughly 367 ml.⁴ That matters because if someone needs a certain amount of ventilation to clear carbon dioxide, and a clinician bumps up EPAP without also raising IPAP, the patient can end up under-ventilated even though the machine settings look adequate on paper.

This is a common source of confusion. People sometimes assume that more pressure in any direction means more ventilation. In reality, the absolute value of EPAP is not what drives ventilation; the gap between the two pressures is. A patient on IPAP 20 / EPAP 10 gets the same driving pressure as someone on IPAP 14 / EPAP 4, even though the raw numbers look very different. The higher EPAP patient has more airway splinting and more help keeping lung volume up, but not more ventilatory support per breath.

How the Two Pressures Work in Obstructive Sleep Apnea

In obstructive sleep apnea, the throat repeatedly collapses during sleep, blocking airflow. Standard CPAP treats this by delivering a single continuous pressure that holds the airway open. Bilevel therapy (BiPAP) takes a different approach: EPAP splints the airway open during exhalation, while IPAP provides a higher boost during inhalation. Because the forces that collapse the upper airway differ between inspiration and expiration, setting each phase independently can eliminate obstructive events at a lower expiratory pressure than a single fixed CPAP level would require.⁵

This has practical consequences for comfort. Many people who struggle with CPAP find exhaling against a fixed high pressure uncomfortable, like breathing out through a straw. With bilevel therapy, the pressure drops during exhalation, making it feel more natural. The EPAP only needs to be high enough to keep the airway from collapsing, while the IPAP handles the ventilatory assist. For some patients, this split is the difference between tolerating therapy nightly and abandoning it. The original research on independently adjustable IPAP and EPAP specifically noted that lower expiratory pressures could reduce the side effects associated with conventional CPAP and improve long-term compliance.⁶

Obesity Hypoventilation and Other Ventilatory Conditions

Bilevel therapy really shows its value in conditions where the problem goes beyond a floppy airway. People with obesity hypoventilation syndrome, severe COPD, neuromuscular diseases, or chest wall deformities often need active help moving enough air. In these patients, the EPAP and IPAP serve clearly distinct roles: EPAP is titrated to overcome any upper airway obstruction, while IPAP is gradually increased to augment ventilation with the goal of normalizing carbon dioxide levels.⁷

This two-target approach is one of the main reasons bilevel devices exist. A person whose airway stays open fine but whose breathing muscles are too weak to ventilate adequately does not need high EPAP. They need a wide gap between IPAP and EPAP to move enough air. Conversely, someone with severe obstructive sleep apnea but strong respiratory muscles might need fairly high EPAP to keep the airway patent but only a modest gap above it. Understanding which pressure to adjust, and why, prevents the common mistake of simply cranking both numbers up together.

Effects on the Heart and Circulation

Positive airway pressure does not just affect the lungs. It changes pressures inside the chest, which in turn affects how blood flows back to the heart and how easily the heart pumps it forward. For people with chronic heart failure and reduced heart function, bilevel therapy has shown some striking hemodynamic benefits. In patients with systolic dysfunction, bilevel PAP dropped systolic blood pressure from about 136 to 124 mmHg, slowed heart rate from roughly 85 to 75 beats per minute, and cut systemic vascular resistance by about a quarter. Meanwhile, cardiac output rose from around 5.1 to 6.4 liters per minute, and ejection fraction improved from about 29% to 34%.⁸

These effects emerge from the interplay of both pressures. EPAP increases pressure inside the chest throughout the breathing cycle, which reduces the amount of blood pooling in the veins returning to the right side of the heart. For a failing heart that is volume-overloaded, this unloading can be therapeutic. IPAP then further reduces the work of breathing, lowering oxygen demand. The combined effect explains why bilevel therapy is sometimes used as a bridge intervention during acute heart failure exacerbations, though the balance has to be carefully managed, because too much positive pressure in someone with low blood volume or right heart failure can drop blood pressure dangerously.

When a Wider Gap Causes Problems

The intuition that “more pressure support equals better treatment” has a ceiling, and in some cases it backfires. A wider gap between IPAP and EPAP can over-ventilate a patient, blowing off too much carbon dioxide. When CO₂ drops below the threshold that triggers the brain’s drive to breathe, the result is a central apnea, a pause in breathing caused not by obstruction but by the brain temporarily stopping its respiratory signals.

Research has shown that higher bilevel pressure differences worsened central apnea events in about 28% of patients studied, while only about 7% improved.⁹ During REM sleep the picture was different: central apneas improved while hypopneas and obstructive apneas got worse. This paradox means that a bilevel setting that works well during one sleep stage can create problems during another. For patients who have a mix of obstructive and central events, sometimes called complex sleep apnea, setting the IPAP-EPAP gap too aggressively to treat the obstructive events can make the central ones proliferate. Clinicians often need to find a compromise, or switch to adaptive servo-ventilation, which adjusts pressure support breath-by-breath to avoid this problem.

Leaks, Aerophagia, and Other Practical Headaches

Bilevel therapy depends on a sealed system to deliver the right pressures. When the mask leaks, the machine struggles to reach and maintain IPAP. Bench testing of industrial masks found that as intentional leak size increased, the ventilator’s ability to achieve and sustain IPAP dropped across all simulated lung conditions, reducing delivered breath volume by up to 48 ml.¹⁰ Interestingly, EPAP maintenance and the ventilator’s ability to detect when a patient starts and stops breathing were less affected by leaks. So a leak primarily undermines the inspiratory boost, which is exactly the pressure that drives ventilation. A patient with a leaky mask might still have an adequately splinted airway (EPAP effect) but lose the ventilatory support they need (IPAP effect).

There is also the issue of air swallowing, known as aerophagia. Higher pressures, especially higher IPAP, push air not only into the lungs but sometimes into the esophagus and stomach. This causes bloating, discomfort, and belching, and in extreme cases can be medically dangerous. A case report described a patient who developed abdominal compartment syndrome from gastric overdistension caused by aerophagia during noninvasive ventilation, leading to sudden respiratory and cardiovascular collapse.¹¹ That is an exceptionally rare outcome, but more routine stomach bloating is one of the most common complaints from bilevel users. Keeping pressures at the minimum effective levels, rather than overshooting, helps manage this.

Other common problems include mouth drying (especially when EPAP is high and air flows continuously past oral tissues), skin irritation at the mask seal, and claustrophobia. Most of these improve with mask fitting adjustments, humidification, or modest pressure changes rather than wholesale therapy abandonment.

Bilevel Therapy in Children

Children are not small adults when it comes to respiratory physiology, but the principles of IPAP and EPAP apply to pediatric patients similarly. In a study of children receiving noninvasive ventilation at typical starting settings of 12 cmH₂O for inspiration and 6 cmH₂O for expiration, carbon dioxide levels dropped from about 45 to 39 mmHg within the first hour, breathing rates slowed from around 45 to 33 breaths per minute, and oxygenation roughly doubled. No adverse circulatory effects were noted, though minor complications like nasal bridge skin breakdown did occur.¹²

Pediatric pressures are generally lower than adult settings, and children are particularly sensitive to mask fit because their faces are smaller and more varied in shape. Leak management matters even more here, because the tidal volumes involved are smaller and a 48 ml loss from leaks represents a proportionally larger fraction of each breath. EPAP in children often starts around 4 to 6 cmH₂O, with IPAP titrated upward based on gas exchange and comfort. Nasal masks are preferred over full-face masks in younger children because of aspiration concerns and because children are more likely to vomit during sleep.

Newer Approaches to Pressure Delivery

The basic bilevel concept of two fixed pressures has been around since 1990, and several variations have emerged to improve comfort and adherence. Auto-titrating bilevel devices adjust both IPAP and EPAP throughout the night based on detected events, so the pressures are only as high as needed at any given moment. Volume-assured modes add another layer of intelligence by targeting a specific breath volume and adjusting the pressure support within a set IPAP range to achieve it, which is useful for patients whose ventilatory needs fluctuate.

One of the more recent innovations takes a different approach entirely. Rather than maintaining a fixed EPAP throughout the entire breathing cycle, some newer devices lower pressure during a portion of exhalation, then restore it near the end of expiration before the next breath begins. A randomized trial of one such technology compared it with standard CPAP in 48 patients with established obstructive sleep apnea. The newer approach was not inferior at controlling residual breathing events, while reducing unintentional mask leak by roughly 40%.¹³ In a separate comfort assessment of 150 newly diagnosed, CPAP-naive patients, the preference was overwhelming: at a baseline pressure of 13 cmH₂O, 84% preferred the pressure-drop technology over standard CPAP, and when given a range of drop options, 95% ultimately chose it.¹⁴

These findings reinforce a consistent theme: much of the discomfort people associate with positive airway pressure therapy comes from exhaling against a sustained positive pressure. Technologies that reduce EPAP even briefly during the exhalation phase appear to make a meaningful difference to how the therapy feels, without sacrificing effectiveness. For the millions of people prescribed PAP therapy who either abandon it or use it inconsistently, the IPAP-EPAP relationship may ultimately be less about raw numbers and more about how dynamically those pressures respond to each breath.

Common Misconceptions Worth Clearing Up

A few misunderstandings come up repeatedly in online forums and even in clinical settings. The first is that BiPAP is always “stronger” than CPAP. In reality, a BiPAP set to IPAP 10 / EPAP 10 is functionally identical to CPAP at 10 cmH₂O; there is no pressure support because there is no gap. Bilevel therapy only differs from CPAP when the two pressures are set to different values. People sometimes get prescribed bilevel devices at settings that provide minimal or no actual pressure support, which misses the point of having two adjustable pressures in the first place.

The second misconception is that EPAP and PEEP (positive end-expiratory pressure, used on ventilators in hospital settings) are completely different things. Physiologically, they do the same job: maintain a baseline positive pressure in the airway at the end of expiration. The terminology differs mostly based on the device delivering it. EPAP is the term used with noninvasive bilevel devices, while PEEP is used with invasive ventilators and some ICU-grade noninvasive machines. If you understand one, you functionally understand the other.

The third is that higher numbers always mean sicker patients. While it is true that very high IPAP settings (above 20 to 25 cmH₂O) tend to be reserved for people with significant ventilatory failure, EPAP levels are driven by a completely separate clinical variable, namely how collapsible the airway is or how much end-expiratory lung volume the patient needs. Someone could have a high EPAP and low IPAP, or vice versa, and those two patterns reflect entirely different underlying problems. Reading too much into the numbers without understanding what each one targets leads to unnecessary anxiety for patients checking their own device data.